arrow
Back
T

Takashi Hisamatsu

Dentistry and Pharmaceutical Sciences

26H-index
237Paper Count
2.3KCitation Count
Published Papers 105
Publication Date
Optimal blood pressure levels for patients with atrial fibrillation who are on undergoing anticoagulant therapy: a large-scale real-world data (F-CREATE project)
err2025-11-19
err0
PREAI
errShintaro Ishida; Toshiki Maeda; Takako Fujii; Makiko Abe; Miki Kawazoe; Chikara Yoshimura; Takashi Hisamatsu; Hisatomi Arima
errShare
errSave
Corrigendum to “A cross-sectional study of the gut microbiota associated with urinary and serum equol production status in a general population of Japanese men” [Food Bioscience 71 (2025) 107048]
err2025-11-01
err0
errOAAI
errYukiko Okami; Hisatomi Arima; Shigeki Bamba; Fu Namai; Keiko Kondo; Yuki Ideno; Ayumi Soejima; Haruna Miyakawa; Sayuki Torii; Hiroyoshi Segawa; Mizuki Ohashi; Megumi Kawashima; Takashi Hisamatsu; Aya Kadota; Akira Sekikawa; Akira Fujiyoshi; Katsuyuki Miura
errShare
errSave
Relationship between obesity indices and cognitive function in Japanese men: A cross-sectional study
err2025-10-23
err0
PREAI
errMatsuno, Satoshi; Ozeki, Yuji; Kadowaki, Sayaka; Torii, Sayuki; Kondo, Keiko; Miyagawa, Naoko; Shima, Azusa; Ohashi, Mizuki; Miyazawa, Itsuko; Segawa, Hiroyoshi; Hisamatsu, Takashi; Kadota, Aya; Miura, Katsuyuki
errShare
errSave
AHA’s Life’s Essential-8 cardiovascular health metrics and progression of coronary artery calcification in Japanese men
err2025-08-18
err0
errOAAI
errRajib Mondal; Aya Kadota; Yuichiro Yano; Sayaka Kadowaki; Sayuki Torii; Keiko Kondo; Akiko Harada; Megumi Kawashima; Itsuko Miyazawa; Hiroyoshi Segawa; Takashi Hisamatsu; Yoshiyuki Watanabe; Yoshihisa Nakagawa; Akira Fujiyoshi; Katsuyuki Miura
errShare
errSave
Effectiveness of self-monitoring devices measuring the urinary sodium-to-potassium ratio, urinary salt (sodium) excretion, or salt concentration in foods for blood pressure management: a systematic review and meta-analysis
err2025-02-13
err0
PREAI
errHisamatsu, Takashi; Ueda, Kohei; Arakawa, Kimika; Minegishi, Shintaro; Kinuta, Minako; Kondo, Keiko; Jinnouchi, Hiroshige; Ishihara, Maho; Abe, Makiko; Sakima, Atsushi; Miura, Katsuyuki; Arima, Hisatomi
errShare
errSave
SCN5A variant type-dependent risk prediction in Brugada syndrome
err2025-02-11
err0
PREAI
errAizawa, Takanori; Makiyama, Takeru; Huang, Hai; Imamura, Tomohiko; Fukuyama, Megumi; Sonoda, Keiko; Kato, Koichi; Hisamatsu, Takashi; Nakamura, Yuko; Hoshino, Kenji; Ozawa, Junichi; Suzuki, Hiroshi; Yasuda, Kazushi; Aoki, Hisaaki; Kurita, Takashi; Yoshida, Yoko; Suzuki, Tsugutoshi; Nakamura, Yoshihide; Ogawa, Yoshiharu; Yamagami, Shintaro; Morita, Hiroshi; Yuasa, Shinsuke; Fukuda, Masakazu; Ono, Makoto; Kondo, Hidekazu; Takahashi, Naohiko; Ohno, Seiko; Nakagawa, Yoshihisa; Ono, Koh; Horie, Minoru
errShare
errSave
Efficacy and safety of obefazimod for the fourth and sixth year of open-label maintenance treatment in patients with moderately to severely active ulcerative colitis (UC): 2-year interim analysis after dose de-escalation to 25 mg
err2025-01-22
err0
PREAI
errDanese, S.; Sands, B. E.; Dulai, P. S.; Peyrin-Biroulet, L.; Dubinsky, M.; Tilg, H.; Siegmund, B.; Hisamatsu, T.; Shan, K.; Ploncard, P.; Jacobstein, D.; Cataldi, F.; Rabbat, C.; Vermeire, S.
errShare
errSave
Efficacy and safety of subcutaneous guselkumab induction therapy in patients with moderately to severely active Crohn's disease: Results through Week 48 from the phase 3 GRAVITI study
err2025-01-22
err0
PREAI
errHart, A.; Panaccione, R.; Steinwurz, F.; Danese, S.; Hisamatsu, T.; Cao, Q.; Olurinde, M.; Vetter, M. L.; Yang, Z.; Wang, Y.; Johanns, J.; Terry, N. A.; Sands, B. E.; D'Haens, G.
errShare
errSave
Early Histologic Response and Remission are Associated With Objective Control of Inflammation After One Year of Treatment With Mirikizumab in Moderately-to-Severely Active Crohn's Disease
err2025-01-22
err0
PREAI
errMagro, F.; Jairath, V; De Hertogh, G.; Feagan, B.; Harpaz, N.; Hisamatsu, T.; D'Haens, G.; Pai, R.; Yu, G.; Tao Luo, W.; Protic, M.; Hon, E.; Moses, R.; Escobar, R.; Reinisch, W.
errShare
errSave
P0636 Impact of obefazimod treatment on histologic and combined histologic and endoscopic outcomes in patients with moderately to severely active ulcerative colitis: results from the Phase 2b open-label maintenance study
err2025-01-22
err0
PREAI
errMagro, F.; Peyrin-Biroulet, L.; Biedermann, L.; Sands, B. E.; Danese, S.; Dulai, P. S.; Dubinsky, M.; Tilg, H.; Siegmund, B.; Hisamatsu, T.; Shan, K.; Jacobstein, D.; Cataldi, F.; Rabbat, C.; Vermeire, S.
errShare
errSave
Efficacy and safety of subcutaneous guselkumab induction therapy in patients with Ulcerative Colitis: Results through week 12 from the phase 3 ASTRO study
err2025-01-22
err0
PREAI
errPeyrin-Biroulet, L.; Allegretti, J. R.; Danese, S.; Germinaro, M.; Baker, T.; Alvarez, Y.; Jorgens, S.; Jiang, L.; Zhang, H.; Hisamatsu, T.; Rubin, D. T.; Long, M.
errShare
errSave
Lack of significance of treatment-emergent anti-drug antibodies on efficacy of mirikizumab in patients with moderately-to-severely active Crohn's Disease: Results from the VIVID-1 study
err2025-01-22
err0
PREAI
errJairath, V; Ananthakrishnan, A.; Ben-Horin, S.; D'Haens, G.; Hisamatsu, T.; Sands, B.; Fisher, D. A.; Protic, M.; Moses, R.; Yu, G.; Chan-Diehl, F.; Vermeire, S.
errShare
errSave
Integrated summary of safety of obefazimod for patients with moderately to severely active ulcerative colitis
err2025-01-22
err0
PREAI
errVermeire, S.; Peyrin-Biroulet, L.; Danese, S.; Dubinsky, M.; Dulai, P. S.; Tilg, H.; Siegmund, B.; Hisamatsu, T.; Shan, K.; Jacobstein, D.; Cataldi, F.; Rabbat, C.; Sands, B. E.
errShare
errSave
Efficacy by baseline disease characteristics of subcutaneous guselkumab induction therapy in patients with moderately to severely active Crohn's disease: Results at Week 12 from the phase 3 GRAVITI study
err2025-01-22
err0
PREAI
errD'Haens, G.; Hisamatsu, T.; Steinwurz, F.; Hart, A.; Liu, W.; Olurinde, M.; Ngqawa, P.; Yang, Z.; Merrall, E.; Terry, N. A.; Sands, B. E.; Panaccione, R.
errShare
errSave
Safety of guselkumab in Inflammatory Bowel Disease up to 1 year: Integrated safety analysis of phase 2 and 3 studies in Crohn's Disease and Ulcerative Colitis
err2025-01-22
err0
PREAI
errSands, B. E.; Panaccione, R.; Danese, S.; Panes, J.; Hisamatsu, T.; D'Haens, G.; Van Rampelbergh, R.; Olurinde, M.; Yee, J.; Baker, T.; Yarandi, S.; Germinaro, M.; Vetter, M. L.; Li, H.; Ballina, M. Rosas; Allegretti, J.; Afzali, A.; Rubin, D. T.
errShare
errSave
Efficacy and safety of dose de-escalation from 50 mg to 25 mg QD of obefazimod maintenance treatment: Analysis of a subset of patients with moderately to severely active ulcerative colitis (UC) who have completed 2 years with 25mg QD
err2025-01-22
err0
PREAI
errDanese, S.; Sands, B. E.; Dulai, P. S.; Peyrin-Biroulet, L.; Dubinsky, M.; Tilg, H.; Siegmund, B.; Hisamatsu, T.; Shan, K.; Ploncard, P.; Jacobstein, D.; Cataldi, F.; Rabbat, C.; Vermeire, S.
errShare
errSave
Low-density lipoprotein particle profiles compared with standard lipids measurements in the association with asymptomatic intracranial artery stenosis
err2024-05-10
err1
errOAAI
errVu, Thien; Yano, Yuichiro; Pham, Huy Kien Tai; Mondal, Rajib; Ohashi, Mizuki; Kitaoka, Kaori; Moniruzzaman, Mohammad; Torii, Sayuki; Shiino, Akihiko; Tsuji, Atsushi; Hisamatsu, Takashi; Okamura, Tomonori; Kondo, Keiko; Kadota, Aya; Watanabe, Yoshiyuki; Nozaki, Kazuhiko; Ueshima, Hirotsugu; Miura, Katsuyuki
errShare
errSave
Relationship Between Hemoglobin Concentration and Cardiovascular Disease Mortality in a 25-Year Follow-up Study of a Japanese General Population ― NIPPON DATA90 ―
err2024-04-25
err2
errOAAI
errKawashima, Megumi; Hisamatsu, Takashi; Harada, Akiko; Kadota, Aya; Kondo, Keiko; Okami, Yukiko; Hayakawa, Takehito; Kita, Yoshikuni; Okayama, Akira; Ueshima, Hirotsugu; Okamura, Tomonori; Miura, Katsuyuki
errShare
errSave
Blood Pressure Phenotypes, Subclinical Cerebrovascular Diseases and Coronary Artery Calcification in Japanese Men
err2024-03-19
err0
PREAI
errBayaraa, Nomin; Yano, Yuichiro; Azahar, Nazar Mohd; Hoang, Phap Tran Ngoc; Hisamatsu, Takashi; Kondo, Keiko; Torii, Sayuki; Miura, Katsuyuki
errShare
errSave
Alcohol Consumption and Cerebral Small- and Large-Vessel Diseases: A Mendelian Randomization Analysis
err2024-02-01
err4
errOAAI
errHisamatsu, Takashi; Tabara, Yasuharu; Kadota, Aya; Torii, Sayuki; Kondo, Keiko; Yano, Yuichiro; Shiino, Akihiko; Nozaki, Kazuhiko; Okamura, Tomonori; Ueshima, Hirotsugu
errShare
errSave